BioCryst Pharmaceuticals | BCRX - Собственный капитал и резервы





Собственный капитал и резервы Изменить Дата
Alnylam Pharmaceuticals USD 1.08B 286.2M 2026-03
BioCryst Pharmaceuticals USD -119.15M 268.74M 2025-12
Chugai Pharma JPY 2.03T 135.62B 2025-12
Daiichi Sankyo JPY 1.71T 57.86B 2025-12
DBV Technologies USD 168.77M 115.92M 2025-12
Enanta Pharmaceuticals USD 126.59M 61.87M 2025-12
Gilead Sciences USD 22.62B 1.16B 2025-12
GlaxoSmithKline GBP 17.42B 1.05B 2026-03
Glaxosmithkline GBP 22.06B 360M 2025-12
Incyte USD 5.62B 455.37M 2026-03
Ionis Pharmaceuticals USD 491.41M 2.32M 2026-03
Karyopharm Therapeutics USD -292.93M 23.67M 2025-12
Neurocrine Biosciences USD 3.41B 154.3M 2026-03
Novavax USD -144.76M 17.01M 2026-03
PTC Therapeutics USD -205.31M 49.56M 2025-12
Regeneron Pharmaceuticals USD 31.42B 166.7M 2026-03
Roche Holding CHF 33.8B 758M 2025-12
Sarepta Therapeutics USD 1.14B 179.5M 2025-12
Ultragenyx Pharmaceutical USD -236M 156M 2026-03
Vertex Pharmaceuticals USD 19.36B 696.1M 2026-03